Recombinant Peromyscus maniculatus Alcohol dehydrogenase 6 (ADH6)

Shipped with Ice Packs
In Stock

Description

Introduction

Recombinant Peromyscus maniculatus Alcohol Dehydrogenase 6 (ADH6) is a genetically engineered enzyme produced to study alcohol metabolism and detoxification pathways in this species. ADH6 belongs to the medium-chain dehydrogenase/reductase (MDR) superfamily and plays roles in oxidizing alcohols and reducing aldehydes, similar to its homologs in other mammals . Its recombinant form enables precise biochemical characterization and application in research models, particularly for understanding ethanol metabolism in Peromyscus maniculatus, a species used in biomedical studies due to its unique ADH-negative mutants .

Expression Systems

  • Yeast: Preferred for eukaryotic post-translational modifications .

  • E. coli: Cost-effective for high-yield production but lacks modifications .

Purification Protocol

  1. Affinity Chromatography: His-tag binding to nickel columns .

  2. Buffer Composition: 20 mM Tris-HCl (pH 8.0), 30% glycerol, 0.15 M NaCl, 1 mM DTT for stability .

  3. Storage: -20°C or -80°C with carrier proteins (e.g., 0.1% BSA) to prevent aggregation .

Applications in Research

  • Antibody Production: Serves as an antigen for generating monoclonal antibodies .

  • Enzyme Kinetics: Used to compare ADH activity across species or under genetic modifications .

  • Toxicology Models: ADH-negative Peromyscus strains help isolate ADH6’s role in allyl alcohol hepatotoxicity .

Comparative Analysis with Human ADH6

FeaturePeromyscus maniculatus ADH6Human ADH6
Gene LocationChromosome 3 (syntenic to human 4q23) Chromosome 4q23
Expression SitesLiver, stomach (assumed)Liver, stomach
Regulatory ElementsNot characterizedGlucocorticoid response element upstream
Substrate PreferenceEthanol, formaldehyde derivatives (inferred)Retinol, lipid peroxidation products

Challenges and Future Directions

  • Substrate Profiling: Comprehensive kinetic studies are needed to define Peromyscus ADH6’s substrate repertoire .

  • Structural Modeling: Cryo-EM or X-ray crystallography could resolve active-site differences compared to human ADH6 .

  • In Vivo Functional Studies: Leveraging CRISPR-edited Peromyscus to validate ADH6’s metabolic roles .

Product Specs

Form
Lyophilized powder. We will preferentially ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary based on purchasing method and location. Consult your local distributor for specific delivery times. All proteins are shipped with normal blue ice packs by default. Request dry ice shipment in advance (extra fees apply).
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50% for your reference.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
ADH6; Alcohol dehydrogenase 6; EC 1.1.1.1; Alcohol dehydrogenase 2; ADH-2
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-375
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Peromyscus maniculatus (North American deer mouse)
Target Names
ADH6
Target Protein Sequence
MSTAGKVIRC KAAVLWKPGA PLTMEEIDVA PPKGKEVRVK MVAAGICGTD IKSLDNKKLA PFCPIIMGHE GTGIVESVGE GVSTVKTGDK VIILCLPQCG ECNTCLNSKN NICKEVRLSG THLTSEGNSR ITCKGKTTYQ YITTGTFSEY IVIKEISVAK VDEDALLEKA CIIGCGFATG FGAAINSAKV SPGSTCAVFG LGGVGLSVIM GCKAAGAARI IAVDTNKDKF AKAKTVGATE CIDPQDFEKP IQQVLFDMMN DGADFTFEVT GNPETVETAL ASCHKDHGVC VIVGSLASWI QLNINSHLFF SGRTLKGSVL GGWKTKEEIP KLVSDYTAKK FNLDPLITHT LTLDKVNEAI QLMKNGQCIR CVLLP
Uniprot No.

Target Background

Protein Families
Zinc-containing alcohol dehydrogenase family, Class-V subfamily
Subcellular Location
Cytoplasm.

Q&A

What is the molecular structure of Peromyscus maniculatus ADH6?

Peromyscus maniculatus ADH6 (Alcohol Dehydrogenase 6, Class V) is a 375 amino acid protein belonging to the zinc-containing alcohol dehydrogenase family. The full amino acid sequence begins with MSTAGKVIRC and continues through a structured catalytic domain containing zinc-binding motifs essential for its enzymatic activity . The protein maintains the general structural features of class V alcohol dehydrogenases, including NAD(H) binding domains and substrate-binding pockets. Unlike some other mammalian ADHs, the deer mouse ADH6 exhibits unique evolutionary adaptations that may relate to metabolic requirements specific to this species.

How does Peromyscus maniculatus ADH6 differ from other alcohol dehydrogenases?

Peromyscus maniculatus ADH6 represents a class V alcohol dehydrogenase that differs from other classes in several key aspects:

  • Substrate specificity: While all ADHs catalyze the oxidation of alcohols, P. maniculatus ADH6 shows tissue-specific expression patterns and somewhat different substrate preferences compared to other ADH classes .

  • Genetic lineage: Research has identified that deer mice possess multiple ADH genes, including Adh-1 (a class I ADH) and Adh-2, which represents a novel class of mammalian ADH with distinct evolutionary origins .

  • Expression profiles: Biochemical analyses suggest P. maniculatus expresses at least three ADH polypeptides in different tissues with varying substrate specificities .

Understanding these differences is crucial when using this protein as a model for comparative studies against human or other mammalian ADH enzymes.

What are the primary catalytic functions of recombinant P. maniculatus ADH6?

Based on homology to other ADH6 enzymes, P. maniculatus ADH6 primarily catalyzes:

  • NAD-dependent oxidation of primary alcohols to corresponding aldehydes

  • Oxidation of secondary alcohols to corresponding ketones

The enzyme forms part of the metabolic pathway responsible for alcohol detoxification in mammals. The recombinant version maintains these catalytic properties, making it suitable for studying alcohol metabolism in controlled experimental settings . The enzyme requires NAD+ as a cofactor for its oxidative activities, and the catalytic reaction follows a sequential ordered mechanism where the coenzyme binds first, followed by the substrate.

How can recombinant P. maniculatus ADH6 be utilized in comparative evolutionary studies?

Recombinant P. maniculatus ADH6 offers valuable insights for evolutionary studies through:

  • Phylogenetic analysis: Comparing ADH6 sequences across mammalian species reveals evolutionary relationships and functional divergence patterns. The deer mouse represents an important model as it exhibits unique ADH gene variants not found in laboratory mice .

  • Structure-function relationship studies: The recombinant protein allows researchers to investigate how sequence variations translate to functional differences in enzyme activity. This can be accomplished through:

    • Site-directed mutagenesis to mimic evolutionary changes

    • Kinetic parameter comparisons across species

    • Structural modeling and docking studies to visualize substrate interactions

  • Adaptive metabolism analysis: Researchers can examine how variations in ADH6 across mammalian lineages relate to dietary adaptations and environmental pressures, particularly regarding alcohol metabolism capacities .

The comparative data obtained can provide insights into how alcohol metabolism evolved across different mammalian lineages in response to varying ecological niches.

What are the best experimental approaches for analyzing substrate specificity differences between P. maniculatus ADH6 and other mammalian ADH enzymes?

For comprehensive substrate specificity analysis:

  • Parallel enzyme kinetics studies:

    • Determine Km and Vmax values for P. maniculatus ADH6 with various substrates

    • Compare kinetic parameters with other mammalian ADHs under identical conditions

    • Use Lineweaver-Burk or Eadie-Hofstee plots to visualize differences

  • Structural analysis approaches:

    • Homology modeling based on crystallographic data from related ADHs

    • Molecular docking of diverse substrates to identify binding pocket differences

    • MD simulations to analyze protein-substrate interactions

  • Isothermal titration calorimetry (ITC):

    • Measure the thermodynamic parameters of substrate binding

    • Determine binding affinity constants for different substrates

    • Compare with human and other mammalian ADH enzymes

  • High-throughput substrate screening:

    • Test activity against libraries of potential substrates

    • Identify unique specificities for evolutionary significance

    • Develop activity profiles for comparison across species

This multi-faceted approach will reveal how P. maniculatus ADH6 differs functionally from other mammalian ADHs and may identify novel substrates or activities specific to this enzyme .

How does the recombinant expression system affect the structural and functional properties of P. maniculatus ADH6?

The choice of expression system significantly impacts recombinant P. maniculatus ADH6 properties:

  • Yeast expression system (as used in ABIN1610357):

    • Advantages: Produces soluble protein with proper folding, contains eukaryotic post-translational machinery

    • Limitations: May introduce yeast-specific glycosylation patterns

    • Effect on structure: Generally maintains native-like conformation with His-tag minimal interference

  • Alternative expression systems:

    • E. coli: Higher yield but may form inclusion bodies requiring refolding

    • Mammalian cells: Better for studying mammalian-specific modifications

    • Cell-free systems: Useful for rapid production but may lack proper folding

  • Tag influence considerations:

    • His-tag impact on structure minimal but may affect metal binding properties

    • Position of tag (N vs C-terminal) can differently impact catalytic activity

    • Removal of tag may be necessary for certain structural studies

When comparing experimental results across studies, researchers should account for these expression system variables. For the most accurate structure-function studies, validation against native enzyme (when available) is recommended .

What are the optimal conditions for measuring P. maniculatus ADH6 enzymatic activity in vitro?

For optimal measurement of P. maniculatus ADH6 enzymatic activity:

  • Buffer composition:

    • 100 mM sodium phosphate or Tris-HCl buffer (pH 7.5-8.5)

    • 150 mM NaCl for stability

    • 0.1-1 mM ZnCl₂ (to maintain zinc cofactor)

  • Reaction conditions:

    • Temperature: 25-37°C (37°C approximates physiological conditions)

    • pH optimum: Typically 7.5-8.5 (determine empirically)

    • NAD⁺ concentration: 1-2 mM (saturating)

    • Substrate concentration range: 0.1-100 mM (for Km determination)

  • Activity measurement methods:

    • Spectrophotometric assay: Monitor NADH formation at 340 nm

    • Calculated using extinction coefficient (ε) of 6,220 M⁻¹cm⁻¹

    • Initial velocity measurements (first 5-10% of reaction)

  • Controls and standards:

    • Heat-inactivated enzyme negative control

    • Commercial ADH from similar sources as positive control

    • Blank reaction without substrate

Researchers should optimize these conditions for their specific experimental setup. The recombinant P. maniculatus ADH6 typically shows >90% purity and is suitable for these biochemical assays when obtained from commercial sources .

What are the most effective protocols for purifying recombinant P. maniculatus ADH6 after expression?

For efficient purification of His-tagged recombinant P. maniculatus ADH6:

  • Immobilized Metal Affinity Chromatography (IMAC):

    • Equilibrate Ni-NTA resin with binding buffer (50 mM Na₂HPO₄, 300 mM NaCl, 10 mM imidazole, pH 8.0)

    • Load cleared lysate onto column

    • Wash with binding buffer containing 20-30 mM imidazole

    • Elute with step gradient of imidazole (100-250 mM)

    • Monitor protein elution by Bradford assay or A280

  • Secondary purification steps:

    • Size exclusion chromatography (Superdex 200) to remove aggregates and obtain homogeneous protein

    • Ion exchange chromatography for removal of charged contaminants

    • Consider affinity tag removal using TEV protease if tag impacts function

  • Quality control:

    • SDS-PAGE analysis with Coomassie staining (should show >90% purity)

    • Western blot using anti-His antibodies

    • Activity assay using standard alcohol substrates

    • Mass spectrometry to confirm identity and integrity

  • Storage considerations:

    • Store at -80°C in 20% glycerol, 50 mM phosphate buffer, pH 7.5

    • Avoid repeated freeze-thaw cycles

    • Add reducing agent (1-5 mM DTT) to prevent oxidation of cysteine residues

This protocol typically yields active enzyme with >90% purity as determined by SDS-PAGE, suitable for most biochemical and structural studies .

How should researchers design experiments to compare P. maniculatus ADH6 with ADH6 from other species?

For robust cross-species ADH6 comparative studies:

  • Standardized expression systems:

    • Express all proteins in the same host (e.g., yeast or E. coli)

    • Use identical purification tags and protocols

    • Confirm similar purity levels (>90%) before comparison

  • Parallel characterization setup:

    • Determine basic parameters (pH optima, temperature stability, cofactor preferences) simultaneously

    • Use identical buffer conditions and substrate concentrations

    • Process all samples in the same analytical batch when possible

  • Kinetic analysis design:

    • Measure initial velocities across a range of substrate concentrations (0.1 × Km to 10 × Km)

    • Analyze data with consistent software and models (Michaelis-Menten, allosteric models)

    • Calculate and compare key parameters (kcat, Km, kcat/Km) with statistical analysis

  • Standardized reporting:

    • Document full experimental conditions in publications

    • Present results in comparative tables showing percent differences

    • Include positive controls (well-characterized ADHs) in experiments

This approach minimizes variables that could confound true species differences. When investigating evolutionary aspects, researchers should include ADH6 from species at varying evolutionary distances to establish meaningful phylogenetic patterns .

How do mutations in the Peromyscus maniculatus ADH6 gene affect enzyme function and stability?

Mutations in P. maniculatus ADH6 can significantly impact enzyme properties in predictable ways based on the location:

  • Catalytic domain mutations:

    • Histidine residues in the zinc-binding motif: Severely reduce or eliminate activity

    • Substrate-binding pocket residues: Alter substrate specificity and Km values

    • NAD⁺-binding residues: Affect cofactor affinity and catalytic rate

  • Stability-affecting mutations:

    • Core hydrophobic residues: May destabilize tertiary structure

    • Surface exposed cysteines: Can form aberrant disulfide bonds affecting stability

    • Interface residues for dimerization: May disrupt quaternary structure

  • Experimental approaches to study mutation effects:

    • Site-directed mutagenesis to introduce specific changes

    • Thermal shift assays to measure stability changes (ΔTm)

    • Circular dichroism to assess secondary structure alterations

    • Activity assays with increasing denaturant concentrations

  • Natural variants analysis:

    • The deletion of the Adh-1 gene in ADH-negative deer mice provides a natural model for studying compensatory mechanisms

    • Comparing DNA sequences from different deer mouse populations can identify naturally occurring variants for structure-function analysis

Understanding these structure-function relationships helps elucidate evolutionary adaptations and can inform protein engineering efforts for enhanced stability or altered substrate specificity .

What techniques are most effective for studying the three-dimensional structure of P. maniculatus ADH6?

To elucidate the 3D structure of P. maniculatus ADH6:

These complementary approaches provide comprehensive structural insights, particularly when integrated with functional data from enzyme kinetics and substrate binding studies .

What are the key considerations when designing inhibitor studies for P. maniculatus ADH6?

For robust inhibitor studies with P. maniculatus ADH6:

  • Inhibitor selection strategy:

    • Competitive inhibitors: Target the substrate binding site

    • Uncompetitive inhibitors: Bind only to enzyme-substrate complex

    • Mixed inhibitors: Affect both free enzyme and enzyme-substrate complex

    • Start with known inhibitors of other mammalian ADHs as a baseline

  • Experimental design considerations:

    • Determine inhibition mechanism through Lineweaver-Burk plots

    • Calculate Ki values under standardized conditions

    • Test inhibitor specificity against other ADH classes

    • Investigate structure-activity relationships with related compounds

  • Technical execution:

    • Pre-incubate enzyme with inhibitor before adding substrate

    • Include solvent controls (for DMSO or ethanol-dissolved inhibitors)

    • Use multiple inhibitor concentrations (0.1-10× expected Ki)

    • Account for potential time-dependent inhibition

  • Advanced analysis:

    • IC₅₀ determination with statistical validation

    • Residence time measurements for tight-binding inhibitors

    • Thermal shift assays to confirm direct binding

    • Computational docking to predict binding modes

  • Comparative dimensions:

    • Test the same inhibitors against human ADH6 for translational relevance

    • Compare with inhibition profiles of other mammalian ADHs

    • Correlate inhibition patterns with structural differences

These methodological considerations ensure reliable inhibition data that can inform drug development and provide insights into active site architecture and enzyme mechanism .

How should researchers interpret differences in substrate specificity between P. maniculatus ADH6 and other mammalian ADH enzymes?

When analyzing substrate specificity differences:

  • Quantitative interpretation framework:

    • Calculate specificity constants (kcat/Km) for each substrate across species

    • Normalize data to a common substrate for relative comparison

    • Construct specificity profiles using radar charts for visual comparison

    • Calculate Z-scores to highlight statistically significant differences

  • Structure-based interpretation:

    • Map amino acid differences to the 3D structural model

    • Focus on residues lining the substrate binding pocket

    • Correlate binding pocket volume with substrate size preferences

    • Use molecular docking to visualize altered binding modes

  • Evolutionary context analysis:

    • Consider the ecological and dietary factors for P. maniculatus

    • Assess whether differences align with known selective pressures

    • Compare with other species occupying similar ecological niches

    • Examine substrate preferences in the context of natural alcohol exposure

  • Methodological considerations for interpretation:

    • Account for different expression systems when comparing published data

    • Consider the impact of purification tags on substrate binding

    • Ensure pH and temperature conditions are standardized

    • Use multiple substrate concentrations to establish accurate kinetic parameters

This comprehensive interpretation approach helps distinguish functionally significant differences from experimental variation and provides evolutionary context to biochemical findings .

What statistical approaches are most appropriate for analyzing kinetic data from P. maniculatus ADH6 experiments?

For robust statistical analysis of ADH6 kinetic data:

  • Primary data fitting methods:

    • Non-linear regression using Michaelis-Menten equation for standard kinetics

    • Enzyme inhibition models (competitive, non-competitive, uncompetitive)

    • Global fitting for complex mechanisms with multiple parameters

    • Bootstrap analysis to estimate parameter confidence intervals

  • Statistical comparison tests:

    • ANOVA for comparing multiple experimental conditions

    • Tukey's or Dunnett's post-hoc tests for multiple comparisons

    • t-tests for pairwise comparisons of kinetic parameters

    • Mann-Whitney U test for non-normally distributed data

  • Experimental design considerations:

    • Minimum of triplicate independent experiments

    • Technical replicates within each experiment (n≥3)

    • Power analysis to determine appropriate sample size

    • Randomization of sample processing order

  • Advanced statistical approaches:

    • Principal component analysis for multivariate substrate specificity data

    • Hierarchical clustering to identify substrate preference patterns

    • Bootstrapping for robust parameter estimation

    • Monte Carlo simulations for error propagation in complex calculations

  • Visualization techniques:

    • Include residual plots to verify goodness of fit

    • Forest plots for comparing kinetic parameters across conditions

    • Heat maps for visualizing substrate preference patterns

    • Box plots showing data distribution and outliers

These statistical approaches ensure reliable interpretation of kinetic data while accounting for experimental variability and complex enzyme behaviors .

How can researchers reconcile contradictory findings in the literature regarding ADH6 function across species?

When addressing conflicting literature findings:

  • Systematic comparative analysis:

    • Create a comprehensive table of contradictory results with experimental conditions

    • Categorize discrepancies by type: substrate specificity, kinetic parameters, expression patterns

    • Identify methodological differences that could explain contradictions

    • Examine species differences in sequence and structure as potential explanations

  • Methodological reconciliation:

    • Standardize units and reference conditions across studies

    • Account for different expression systems and purification methods

    • Consider the impact of different assay methods and detection limits

    • Re-analyze raw data when available using consistent analytical approaches

  • Targeted validation experiments:

    • Design experiments specifically addressing contradictory points

    • Include positive and negative controls relevant to contradictory findings

    • Use multiple independent methods to verify key findings

    • Consider reproducibility across different laboratories

  • Biological context integration:

    • Consider tissue-specific expression patterns when interpreting functional differences

    • Examine whether contradictions align with evolutionary adaptations

    • Investigate potential post-translational modifications affecting activity

    • Account for the physiological relevance of in vitro conditions

  • Meta-analysis techniques:

    • Apply formal meta-analysis when sufficient quantitative data exists

    • Weight studies based on methodological rigor and sample size

    • Identify moderator variables that explain heterogeneity in findings

    • Present forest plots to visualize effect sizes across studies

This structured approach helps resolve apparent contradictions and can advance understanding of true species differences versus methodological artifacts in ADH6 research .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.